MET
FinancialsMetLife
Price Chart
Market Data
Financials
XBRL · SEC EDGAR2007–2025(19yr)| Metric | FY 2007 | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025Latest | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.2B | $51.0B | $41.1B | $52.7B | $70.3B | $68.2B | $68.2B | $73.3B | $70.0B | $63.5B | $62.3B | $67.9B | $69.6B | $67.8B | $71.1B | $69.9B | $66.9B | $71.0B | $77.1B | +8.6% |
| Net Income | $4.3B | $3.2B | -$2.2B | $2.8B | $7.0B | $1.3B | $3.4B | $6.3B | $5.3B | $800.0M | $4.0B | $5.1B | $5.9B | $5.4B | $6.6B | $2.5B | $1.6B | $4.4B | $3.4B | -23.7% |
| Net Margin | 9.2% | 6.3% | -5.5% | 5.3% | 9.9% | 1.9% | 4.9% | 8.6% | 7.6% | 1.3% | 6.4% | 7.5% | 8.5% | 8.0% | 9.2% | 3.6% | 2.4% | 6.2% | 4.4% | -1.9pp |
| ROA | — | 0.64% | -0.42% | 0.38% | 0.87% | 0.16% | 0.38% | 0.70% | 0.60% | 0.09% | 0.56% | 0.75% | 0.80% | 0.68% | 0.86% | 0.38% | 0.23% | 0.65% | 0.45% | -0.2pp |
| EPS (Diluted) | $5.48 | $4.14 | $-2.89 | $3.00 | $6.29 | $1.12 | $2.91 | $5.42 | $4.57 | $0.63 | $3.62 | $4.91 | $6.06 | $5.68 | $7.31 | $2.91 | $1.81 | $5.94 | $4.71 | -20.7% |
1. THE BIG PICTURE
MetLife is currently a study in the tension between operational scale and market volatility. While MetLife is successfully pivoting toward high-volume institutional business lines like pension risk transfers, its bottom line remains tethered to the fluctuating value of its massive investment portfolio. The central thesis for MetLife is whether its "all-weather" strategy can eventually decouple core earnings from the "noise" of derivative and investment losses.
2. WHERE THE RISKS HIT HARDEST
MetLife’s status as one of the largest institutional investors in the U.S. is threatened by interest rate volatility because rapid rate changes can reduce investment spreads and increase cash outflows for derivative settlements (Risks). Furthermore, the strategic priority to grow the Retirement and Income Solutions (RIS) segment is threatened by equity market downturns; because these products often feature guaranteed benefits, a market drop simultaneously reduces fee income from assets under management while increasing MetLife’s potential benefit exposure (Business/Risks). Finally, the "New Frontier" focus on international expansion is vulnerable to regulatory and tax shifts, as evidenced by a value-added tax adjustment in Mexico that recently dragged down Latin American earnings (8-K).
3. WHAT THE NUMBERS SAY TOGETHER
The most recent data reveals a sharp divergence between MetLife’s sales momentum and its actual profitability. In the fourth quarter of 2025, premiums and fees surged 29%, yet net income plummeted 37% (8-K). This gap was primarily driven by net derivative and investment losses, which overshadowed "record" adjusted earnings in the core business. While MetLife leads its peer group in revenue growth at 8.6%, it trails the entire group in efficiency, posting the lowest net margin (5.5%) and the lowest Return on Assets (0.5%) (Peer Benchmarking). This suggests that while MetLife is winning the battle for volume—particularly in MetLife Investment Management, which saw earnings grow 275%—it is doing so with a much thinner margin for error than peers like Chubb or Travelers. Supplemental signals show short interest is low at 1.9% of the float, suggesting that despite compressed margins, there is little active betting against MetLife's recovery.
4. IS IT WORTH IT AT THIS PRICE?
At a forward P/EP/EPrice-to-Earnings ratio — share price divided by annual earnings per share; how much investors pay per dollar of profit. Higher P/E = higher growth expectations of 6.5x, the market is pricing in roughly 0.5% long-term growth (CAPM analysis). This represents a 39% discount to the peer median multiple of 10.7x. MetLife appears attractively valued because this price implies a near-stagnant future that is contradicted by its actual 8.6% revenue growth—the highest in its peer group. The market is likely penalizing MetLife for its low 0.5% ROAROAReturn on Assets — net income as a percentage of total assets. For banks, 1%+ is generally considered strong, but this is arguably offset by a robust capital return program; MetLife’s 6.8% buyback yield is the second-highest among its peers (Peer Benchmarking). If MetLife’s growth were to align with even a modest GDP-pace of 2.5%, the sensitivity analysis suggests a justified multiple of 16.4x, indicating significant upside if management can stabilize the bottom line.
5. WHAT WOULD CHANGE THIS VIEW?
- Cautious if net margins continue to trend downward; the metric has already compressed from 6.2% to 4.4% on an annual basis (XBRL).
- Constructive if MetLife Investment Management (MIM) maintains its triple-digit growth trajectory, as this would shift the business mix toward higher-margin, fee-based income that is less capital-intensive than traditional insurance.
6. BOTTOM LINE
Structural Advantage: Massive institutional scale and a multi-channel distribution network that allow it to dominate high-entry-barrier markets like pension risk transfers. Bottom Line: MetLife is a growth leader currently priced like a laggard, offering a high-yield entry point for investors who believe its scale will eventually overcome its margin volatility.
1. Top 5 Material Risks
- Interest Rate Volatility: Rapidly increasing or sustained low interest rates can reduce or eliminate investment spreads, harm the fair value of fixed income securities, and increase cash outflows for derivative settlements.
- Equity Market Downturns: Declines in equity markets reduce fee income derived from assets under management and increase potential benefit exposure for variable annuity and life insurance products with guaranteed benefits.
- Credit Spread Fluctuations: Widening credit spreads can increase borrowing costs and decrease fee income, while a sustained decrease in spreads reduces the yield on future investments.
- Counterparty and Obligor Default: Economic downturns or corporate malfeasance increase the risk of defaults on fixed income securities, mortgage loans, and reinsurance obligations, potentially requiring increased valuation allowances.
- Regulatory and Legal Changes: Shifts in insurance, tax, or financial services regulation can increase compliance costs, necessitate higher capital and reserve requirements, and limit the ability to offer current products.
2. Company-Specific Risks
- Closed Block Funding: MetLife may be required to fund shortfalls in the closed block assets established during the MLIC demutualization if those assets and their cash flows are insufficient to cover guaranteed benefits.
- Brighthouse Separation: MetLife faces ongoing risks related to the separation from Brighthouse, including the potential failure to realize expected tax benefits or exposure to litigation and financial risks if Brighthouse fails as a standalone entity.
- Policyholder Trust Governance: The MetLife Policyholder Trust may disproportionately influence stockholder votes on fundamental corporate actions, potentially complicating corporate governance and increasing costs related to the trust's termination.
- Statutory Reserve Financing: MetLife’s ability to finance statutory life insurance reserves is sensitive to its credit ratings; a decline in ratings or limited market capacity could increase financing costs or harm statutory capitalization.
3. Regulatory/Legal Risks
- Capital Standards: MetLife is subject to evolving solvency standards and potential enhanced capital requirements, including group capital standards or insurer capital standards, which may increase reserve requirements and reporting costs.
- Tax Law Interpretations: Changes in tax laws or interpretations could increase MetLife’s effective tax rate, reduce the value of deferred tax assets, and make tax-preferred products like life insurance and annuities less attractive to consumers.
- Litigation Exposure: MetLife faces potential class actions and regulatory investigations regarding sales practices, underwriting, claims payments, and fiduciary duties, where outcomes are difficult to predict and could result in significant financial or reputational harm.
- Liquidation Risk: MetLife, Inc. could be compelled to undergo FDIC liquidation if it becomes insolvent, which could impose losses on stockholders and creditors and result in charges assessed against MetLife in connection with other financial company liquidations.
4. Financial Impact Map
Interest Rate Risks → Net Investment Income / Investment Spread → Fluctuations in interest rates impact the yield on general account investments and the cost of crediting rates. Equity Market Risks → Fee Income → Revenues from variable annuity and institutional asset management services are directly tied to the fair value of assets under management. Credit Spread Risks → Borrowing Costs / Product Fee Income → Widening spreads increase borrowing costs; changes in spreads impact the discount rate used to calculate liabilities for future policy benefits. Counterparty/Obligor Default → Realized Losses / Impairments → Defaults on fixed income securities and mortgage loans directly impact net income through impairments and valuation allowances. Regulatory/Tax Changes → Effective Tax Rate / Operating Expenses → Changes in tax laws impact the value of deferred tax assets and liabilities; new regulations increase compliance and capital reserve costs.
Recent Filings
| Form | Filed | Period |
|---|---|---|
| 10-K | Feb 2026 | Dec 2025 |
| 8-K | Feb 2026 | — |
| 10-Q | Nov 2025 | Sep 2025 |
| 14A | Apr 2025 | — |
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
MetLife Investment Management Appoints Andrea Drasites Global Head of Real Estate and Agricultural Finance
- ▸Andrea Drasites appointed Global Head of Real Estate and Agricultural Finance
- ▸Effective date for new role is October 1, 2026
- ▸Drasites joins from Blackstone after 13-year tenure
- ▸MIM manages $108.9 billion in real estate and agricultural assets
- ▸Succeeds Robert Merck following his 2025 retirement
MetLife Q4 Revenue $24.19B Misses Estimates by 9.3%, Shares Down 12%
- ▸MetLife Q4 revenue $24.19B, +22.6% YoY, missed estimates by 9.3%
- ▸Jackson Financial Q4 revenue $2.01B, +719% YoY, beat estimates by 4.4%
- ▸Unum Group Q4 revenue $3.25B, flat YoY, missed estimates by 1.1%
- ▸Life insurance sector average share price down 9% since Q4 earnings reports
- ▸Jackson Financial shares down 11.9% despite revenue beat
MetLife reaffirms 2026 outlook targeting double-digit adjusted EPS growth and 15-17% ROE
- ▸Targeting double-digit adjusted EPS growth for 2026
- ▸Adjusted ROE target set at 15% to 17% for 2026
- ▸Confirmed Q1 2026 dividend on Series A floating-rate preferred shares
- ▸Projected 2028 revenue of $83.8B and earnings of $6.3B
- ▸Group Benefits and Retirement and Income Solutions segments showing solid earnings growth